Replies to post #805744 on NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

I agree, H2R, that the company is almost likely now answering questions from the CHM meeting's letter to "clean up" all issues so that they meet the exact requirements of what the regulatory board wants in order to approve DCVax.
Thanks to Lykiri for bringing us the news that the November 29-30 CHM meeting almost certainly advised on DCVax-L. And thanks to Flipper for bringing us details on what happens after the CHM meeting, including that they seldom just say "yes", but usually have a to-do-list to "clean up" details before likely approval. (Which is why we don't get immediate news on approval).

BTW, Longs understand that Linda and company are following the advice of their "army of consultants" and the regulators on what to share with investors. They are not listening to unidentified posters on this or any stock board. H2R, thanks for pointing out that Linda's language at the ASM still fits with what they are doing: continuing to answer questions, just likely not for an RFI, but from the CHM meeting.

[flipper44]

But she should not have told retail on December 29 that she had no idea when a decision might occur (imo) if that is the case (which I believe now is most likely). That’s just not right.

"The second thing is, I can say that we are continuing to be actively engaged. We are going through cycles of questions, follow-up questions, requests for clarification, requests for additional data, information. Those are the cycles that we’re going through. We don’t have a way to predict how much further time it’s going to take. I know that’s what we all want to know. We all want to know the crystal ball, and we do too, but we simply do not have a way to predict how much further time it’s going to take at this point."

Still, I didn’t sell any, because I saw she moved the c level construction starting date to the end of January. It might be another bait, but now it’s looking like the real thing.